These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 32590841)

  • 1. Xpert Mycobacterium tuberculosis/Rifampicin-Detected Rifampicin Resistance is a Suboptimal Surrogate for Multidrug-resistant Tuberculosis in Eastern Democratic Republic of the Congo: Diagnostic and Clinical Implications.
    Bisimwa BC; Nachega JB; Warren RM; Theron G; Metcalfe JZ; Shah M; Diacon AH; Sam-Agudu NA; Yotebieng M; Bulabula ANH; Katoto PDMC; Chirambiza JP; Nyota R; Birembano FM; Musafiri EM; Byadunia S; Bahizire E; Kaswa MK; Callens S; Kashongwe ZM
    Clin Infect Dis; 2021 Jul; 73(2):e362-e370. PubMed ID: 32590841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
    Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
    BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
    Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
    PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the GenoType MTBDRplus assay for detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates in central Ethiopia.
    Bedewi Omer Z; Mekonnen Y; Worku A; Zewde A; Medhin G; Mohammed T; Pieper R; Ameni G
    Int J Mycobacteriol; 2016 Dec; 5(4):475-481. PubMed ID: 27931690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
    Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study.
    Mboowa G; Namaganda C; Ssengooba W
    BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a Molecular Test for Detection of Mycobacterium tuberculosis Isolates Resistant to Rifampicin and Isoniazid.
    Benaissa E; Benlahlou Y; Bssaibis F; Maleb A; Elouennass M
    Clin Lab; 2022 Mar; 68(3):. PubMed ID: 35254025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study.
    Bulabula ANH; Nelson JA; Musafiri EM; Machekano R; Sam-Agudu NA; Diacon AH; Shah M; Creswell J; Theron G; Warren RM; Jacobson KR; Chirambiza JP; Kalumuna D; Bisimwa BC; Katoto PDMC; Kaswa MK; Birembano FM; Kitete L; Grobusch MP; Kashongwe ZM; Nachega JB
    Clin Infect Dis; 2019 Sep; 69(8):1278-1287. PubMed ID: 30759187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the GenoType
    Stephen S; Muzhizhizhi D; Dhibi N; Chidemo T; Samaneka W; Matubu TA; Hakim JG; Chirenje ZM
    Int J Mycobacteriol; 2019; 8(1):83-88. PubMed ID: 30860184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.
    de Vos M; Derendinger B; Dolby T; Simpson J; van Helden PD; Rice JE; Wangh LJ; Theron G; Warren RM
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay.
    Singhal R; Myneedu VP; Arora J; Singh N; Bhalla M; Verma A; Sarin R
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study.
    Ullah I; Shah AA; Basit A; Ali M; Khan A; Ullah U; Ihtesham M; Mehreen S; Mughal A; Javaid A
    BMC Infect Dis; 2016 Aug; 16():413. PubMed ID: 27519406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level.
    Kebede A; Demisse D; Assefa M; Getachew Z; Yenew B; Tedla Y; Ameni G
    BMC Res Notes; 2017 Dec; 10(1):661. PubMed ID: 29191227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
    Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
    PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
    Biadglegne F; Mulu A; Rodloff AC; Sack U
    Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand.
    Anek-Vorapong R; Sinthuwattanawibool C; Podewils LJ; McCarthy K; Ngamlert K; Promsarin B; Varma JK
    BMC Infect Dis; 2010 May; 10():123. PubMed ID: 20487550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter Study of the Accuracy of the BD MAX Multidrug-resistant Tuberculosis Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated With Resistance to Rifampin and Isoniazid.
    Shah M; Paradis S; Betz J; Beylis N; Bharadwaj R; Caceres T; Gotuzzo E; Joloba M; Mave V; Nakiyingi L; Nicol MP; Pradhan N; King B; Armstrong D; Knecht D; Maus CE; Cooper CK; Dorman SE; Manabe YC
    Clin Infect Dis; 2020 Aug; 71(5):1161-1167. PubMed ID: 31560049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil.
    Malaquias TDSS; Ribeiro EP; Dutra TCP; Ricardo M; Salvato R; Bhering M; Bartholomeu DC; Dalla-Costa ER; Viveiros M; Silva ECD; Kritski A
    Rev Soc Bras Med Trop; 2024; 57():e004162024. PubMed ID: 39292021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.